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Enterovirus 71 (EV71) has been recognized as a frequent cause of 
epidemics of hand-foot-and-mouth disease (HFMD) associated 
with severe neurological symptoms. In the spring of 2009, HFMD 
was epidemic in Korea. Severe cases with complication, including 
death, have been reported and it has become a public health issue. 
Most symptomatic EV71 infections commonly result in HFMD 
or herpangina. These clinical manifestations can be associated 
with neurologic syndromes frequently. Neurologic syndromes 
observed in EV71 include meningitis, meningoencephalomyelitis, 
poliomyelitis-like paralytic disease, Guillain-Barré syndrome, 
transverse myelitis, cerebellar ataxia, opsoclonus-myoclonus 
syndrome, benign intracranial hypertension, and brainstem 
encephalitis. Examinations for EV 71 were performed from the 
stools, respiratory secretion or CSF of the children by realtime PCR. 
Gene analysis showed that most of them were caused by EV71 
subgenotype C4a which was prevalent in China, 2008. Public 
health measures including personal and environmental hygiene, 
must to target daycare centers, kindergartens, and schools where 
highly susceptible children congregate. To prevent the spread of 
infection, preschools where transmission persists for more than 
2 incubation periods, have been recommended for closure, and 
trigger criteria for voluntary closure was instituted. During closure, 
operators are to thoroughly clean the centers before they are 
allowed to reopen. In addition, parents are advised to ensure that 
their children adopt a high standard of personal hygiene and to 
keep the infected child at home until full recovery. Because the 
outbreaks occur in a cyclical pattern, surveillance system to predict 
next outbreaks and adequate public health measures to control 
need to be planned for future. Control of EV71 epidemics through 
surveillance and public health intervention needs to be maintained 
in Korea. Future research should focus on understanding of EV71 
virulence, identification of the receptor(s) for EV71, development of 
antiviral agents and development of vaccine. 
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patterns in tissue culture and animals. Recently they have 
been reclassified based on molecular properties into 5 species, 
polioviruses, human enterovirus A, human enterovirus B, human 
enterovirus C, and human enterovirus D. EV71 discovered in 
California in 1969
2) belongs to the human enterovirus A
3). 
In recent epidemics in the Asia-Pacific region, the predominant 
EV71 genotypes were various. In Sarawak during 1997 and 
Singapore during 1998, genotype B3 was most prevalent. EV71 
isolated from patients in the Taiwanese epidemic during 1998 
belonged to genotype C2
4, 5). During the epidemics in Malaysia 
and Singapore in 2000, the predominant genotype was B4
5). And, 
the EV71 outbreaks in Brunei, Sarawak and Singapore in 2006 
were caused by subgenogroup B5 virus
6). EV71 in the outbreak in 
China during 2007-2008 belonged to subgenotype C4a
7, 8). The 
increasing fatality of EV71 infection in recent epidemics has been 
thought to be due to both endemic and epidemic circulation of 
the virus and its evolution. The possible occurrence of inter-typic 
recombination of EV71 may play important roles in the emergence 
of various EV71 subgenotypes with varied virulence and clinical 
manifestations
9).
Since 2000, the laboratory surveillance system for early detection 
of EV71 has been operating in Korea. On 2000, EV71 were 
isolated for the first time from 12 patients with HFMD in Korea. 
They belonged to genotype C3, which has been identified rarely in 
other epidemics in recent years
4, 10). During outbreaks in China in 
2008-2009, the most frequent genotype among the EV71 strains 
isolated from patients was C4a. Genotype C1 viruses were isolated 
from cases of uncomplicated HFMD in Singapore and Sarawak 
during 1998 and in Sarawak and Western Australia during 2005, 
11). It does not appear that a single neurovirulent genotype is 
associated with the severe and fatal cases
12). Further study is needed 
to elucidate the factors influencing the virulence of EV71.
Epidemiology
EV71 infection has the seasonal distribution of a peak in the 
spring and summer months. The transmission of enterovirus 
occurs within families, daycare centers, playgrounds and hospital 
nurseries. More children would be congregating in a limited 
space, which provides a readily available reservoir for the rapid 
circulation of the virus
13). The fecal-to-oral route is considered a 
major transmission route. Long periods of viral shedding may 
account for the widespread transmission of EV71
14). Chung et 
al
15) demonstrated that EV71 is excreted through the stool of 
infected patients for up to 6 weeks. Chang et al
16) presented that 
the culture-positive rate of throat swabs was higher than that of 
Introduction 
On April 18 2009, a 21-month-old girl was referred to the 
pediatric emergency room of the Ewha Womans University 
Mokdong Hospital. She had progressive weakness of the lower 
limb, which had begun 3 days earlier. She was treated at the 
local hospital with the hand-foot-mouth disease (HFMD). Her 
consciousness was clear. She did not have any rash on the skin 
and showed asymmetric lower leg weakness with more severity 
on left leg. She was immunized with 3 doses of inactivated 
polio vaccine. On CSF examination, pleocytosis was noted, but 
chemistry profiles were normal. Because of her acute asymmetric 
flaccid paralysis of lower limb, her stool was sent to the Division of 
Enteric and Hepatitis Viruses, National Institute of Health, Korea 
Centers for Disease Control and Prevention under the impression 
of poliomyelitis-like paralysis due to enterovirus 71 (EV71). On her 
stool examination, EV71 with C1 type was discovered. She was the 
first confirmed case of enterovirus 71 infection on 2009 epidemics 
in Korea
1). In the spring of 2009, a large nationwide outbreak of 
HFMD caused by HEV71 occurred in Korea (Fig. 1). Most of the 
cases were in children <6 years of age and one case was fatal. EV71 
became an emerging concern in Korea. The purpose of this review 
is to overview the recent outbreaks of EV71 infection in Korea 
with exploring epidemiology, virology, clinical manifestations and 
management.  
Virus and genotypes
The genus Enteroviruses are nonenveloped, single-stranded, 
positive-sense viruses in the Picornaviridae (“small RNA virus”) 
family. The human enteroviruses were originally classified 
echoviruses, coxsackieviruses, polioviruses by their replication 
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rectal swabs in the patients. Viruses in throat through the saliva 
or respiratory droplets of patients may be transmitted during the 
acute stage of the disease
17). Although hand-washing precaution is 
important for the period of virus excretion through feces, it is not 
sufficient to limit the spread and transmission of the virus and to 
prevent further epidemics. Therefore, isolation of infected patients 
within single rooms with masks should be considered during 
hospitalization of patients
14). 
It is not clear why a certain region has experienced an increased 
incidence of EV71 infection. A change in clinical presentation 
could coincide with a change in the viral transmission pathway. 
An epidemiological parameters like crowding, lack of sanitation, 
and climate, could enhance virus transmission. An increased 
susceptibility of the population to EV71 infection could be another 
explanation.
Pathogenesis
Infants and young children are very susceptible to EV71 
infection. Immature immunity is therefore suspected to associate 
with increased morbidity and mortality. Moreover individual host 
genetic factors may affect clinical severity 
Lymphopenia, depletion of CD4 and CD8 T lymphocytes, and 
decreased cellular immunity in the peripheral blood were noted in 
patients with brain stem encephalitis and pulmonary edema
18). 
 However, some clinical studies showed that elevated 
cellular immunity was linked with unfavorable outcomes
19). 
The clinical manifestations are reflecting the contribution of 
immunopathological process in addition to cytopathic damage 
to neuronal cells
12, 20, 21). Cytokines in the central nervous system 
and systemic inflammatory responses play important roles in the 
pathogenesis of EV71-associated encephalomyelitis. Destruction 
of vasomotor in the brainstem by EV71 produces autonomic 
nervous system dysregulation prior to the pulmonary edema. The 
pulmonary edema is the result of increased pulmonary vascular 
permeability caused by the direct brainstem lesions and/or a 
systemic inflammatory response syndrome produced by the release 
of cytokines and chemokines.
Clinical Manifestations
Enterovirus serotypes are distinguished by antigenic and genetic 
sequence differences. Although no enterovirus disease is uniquely 
associated with any specific serotype, certain manifestations are 
preferentially associated with specific serotypes.
About half of EV71 infections are asymptomatic
22). Most 
symptomatic EV71 infections commonly result in HFMD or 
herpangina. EV71 infections can cause pharyngitis, herpangina, 
stomatitis, gastrointestinal complaints, pericarditis, ventricular 
dysfunction, macular, maculopapular, vesicular or exanthema
22). 
These clinical manifestations can be associated with neurologic 
syndromes frequently. Children having only febrile illness 
without mucocutaneous manifestations may have neurologic 
complications
23). HEV71 is closely related to coxsackie virus A16 
(CA16), the other major causative agent of HFMD, but unlike 
CA16, HEV71 is also associated with cases of acute neurologic 
disease including poliomyelitis-like paralysis, encephalitis, and 
aseptic meningitis.
Neurologic syndromes observed in EV71 include meningitis, 
meningoencephalomyelitis, poliomyelitis-like paralytic disease, 
Guillain-Barré syndrome, transverse myelitis, cerebellar 
ataxia, opsoclonus-myoclonus syndrome, benign intracranial 
hypertension, and brainstem encephalitis
3, 12) (Table 1).
Neurologic disorders have been prominent in recent epidemics 
of EV71 disease. In the outbreaks in Taiwan in 1998 and in 
Australia in 1999, virological studies found that HFMD and 
herpangina epidemics were caused by EV71 and coxsackievirus 
A16 but the cases presenting with acute pulmonary edema and 
other neurological diseases were caused by brainstem encephalitis 
resulting from acute EV71 infection
16,  24,  25). 
HFMD with EV71-associated neurological syndrome 
has increased continually in many countries during the last 
10 years, especially in the Asia- Pacific region
8, 26). In some 
countries, outbreaks occur in a cyclical pattern every three years, 
Table 1. Outbreak of EV71 Infection and Major Clinical Manifestations in 
Worldwide
Country Year Clinical manifestation                         
USA
USA
USA
USA
Australia
Sweden
Bulgaria
Hungary
France
Japan
Hong King
China
Singapore, Malaysia
Taiwan
China
Korea
1969
1972
1977
1995
1972
1973
1975
1978
1979
1973
1985
1987
1997
1998
2008-9
2009
aseptic meningitis, encephalitis 
aseptic meningitis, encephalitis, HFMD 
aseptic meningitis 
neurologic HFMD 
aseptic meningitis, rash 
HFMD, aseptic meningitis 
aseptic meningitis, encephalitis 
aseptic meningitis, encephalitis 
acute respiratory infection with CNS 
involvement 
aseptic meningitis, HFMD 
aseptic meningitis 
HFMD 
HFMD, aseptic meningitis 
HFMD, encephalitis 
HFMD, meningitis, encephalitis, pulmonary 
edema
aseptic meningitis, encephalitis, HFMD 
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predominantly caused by strains that are distinct from previous 
outbreaks
27). In Singapore, since the first outbreak of HFMD in 
1970, many epidemics have occurred by predominantly circulating 
strain coxsackievirus A16 or EV71, and the largest one was caused 
by EV71 with 3,790 cases and four deaths in 2000
13, 28). In 2006, 
Brunei reported that 1,681 children were affected with three 
deaths resulting from severe neurologic disease
6). In the same year, 
an outbreak of EV71 affected approximately 14,400 children 
in Sarawak, Malaysia
29). In the outbreak of China in 2008, a 
total of 488,955 HFMD cases were reported including 126 fatal 
cases, mostly caused by EV7
17). Possible reasons suggested for the 
outbreaks were mutation of the virus with increased virulence 
and the presence of host factors including the accumulation of 
susceptible populations and individual genetic susceptibility
30, 31).
Ooi et al
32) studied about the clinical risk factors to help detect 
children at risk of neurological involvement. They noticed that total 
duration of fever >or= 3 days, peak temperature >or= 38.5°C and 
history of lethargy were independent risk factors for neurological 
involvement.
Mortality was high in EV71 brainstem encephalitis complicated 
with pulmonary edema, particularly in children below 5 years of 
age. There have been several large epidemics of EV71 infection 
causing high fatalities. The first report of severe epidemics of 
encephalitis and acute flaccid paralysis due to EV71 came from 
Bulgaria in 1975, in which 44 deaths occurred
33). In 1978, 45 
patients died of neurologic diseases with HFMD in Hungary
34). 
Since 1997, three major epidemics have occurred in the Asia-Pacific 
region. They were in Sarawak, Malaysia in 1997, Taiwan in 1998, 
and China in 2008, and 31, 78, and 126 fatal cases were reported, 
respectively
7, 24, 35).  
In Korea, EV71 were isolated for the first time from 12 patients 
with hand foot mouth disease on 2000 laboratory surveillance. 
During 2009 outbreaks in Korea, about 90 % isolates were from 
patients with HFMD and 10% from those with herpangina. Most 
patients with EV71 who presented neurologic symptoms were 
associated with HFMD. They were diagnosed as meningitis or 
meningoencephalitis, and Guillain-Barré syndrome, poliomyelitis-
like paralytic disease and myoclonus. Gene analysis showed that 
most of them were caused by EV71 subgenotype C4a, which was 
prevalent in China in 2008. EV71 infections with severe cases with 
complications including death become a public health issue
1).
During 2009 outbreaks in Korea, 16 patients were hospitalized 
with neurologic manifestations related with HFMD at Ewha 
Womans University Mokdong Hospital (Table 2). Their ages 
ranged from a month to eight years and the mean age was 29 
months. The male to female ratio was 1.7:1 (M:F). Fever resolved 
in 2 to 7 days (mean, 4.5 days) and the range of peak of fever was 
38.0 to 40.1°C (mean, 39.3°C). In most of the patients, neurologic 
symptoms developed between day 2 and day 3 (range, day 1 to day 
5) after the onset of fever or skin lesions. Among the 16 patients, 
the most frequent neurologic manifestation was meningitis 
(62.5%), which included 8 definite cases with meningeal irritative 
symptoms and signs with CSF pleocytosis (>5 cells/mm
3) and 
2 suspected cases in whom spinal tappings were not performed. 
Three cases had Guillain-Barré syndrome and one of them had 
meningoencephalitis. One patient presenting asymmetric lower 
limb weakness (left>right) after HFMD showed enhancement in 
the left anterior horn of the spinal cord (T11 level) on magnetic 
Table 2. Clinical Features of Patients with Enterovirus 71 Associated Neurological Disease in Ewha Womans University Mokdong Hospital
No. Sex
Age
(months)
Clinical presentation
EV71 positivity in clinical sample CSF pleocytosis
(cells/mm
3)
Subgenotype
of EV71 CSF Stool
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
F
M
M
F
M
F
M
F
F
M
M
M
M
F
M
M
42
21
8
21
83
18
34
33
18
27
1
1
8
102
41
3
Meningitis
Myoclonus
Guillain-Barré syndrome
Poliomyelitis-like paralysis
Meningitis
Meningitis
Meningitis, convulsion
Meningitis
Guillain-Barré syndrome
Meningitis
Meningitis
Meningitis
Guillain-Barré syndrome
Meningoencephalitis
Meningitis
Meningitis
ND
ND
-
-
-
-
-
-
-
ND
-
-
-
-
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
ND
ND
14
48
60
880
110
14
40
ND
8
160
70
20
70
11
C4a
C4a
C4a
C1
C4a
C4a
C4a
C4a
C4a
UT
UT
UT
C4a
UT
C4a
C4a
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resonance image. EV71 were detected in the 16 patients presenting 
neurologic manifestations by realtime PCR. Clinical samples 
included stools, respiratory secretion, or cerebrospinal fluid 
obtained from the patients, but viruses were detected from only 
stools. Subgenotypes of enteroviruses were C1 in the poliomyelitis-
like paralytic disease patients, and C4a in eleven patients presenting 
Guillain-Barré syndrome, meningitis or myoclonus. Among the 
patients, only one girl presenting poliomyelitis-like paralytic disease 
still had limping when she was running at three months after 
discharge, but no death or severe complication with serious disease 
was observed in any of the other patients
1).
Diagnosis
For virus isolation and detection, proper selection and handling 
of specimens are most important. Collection of materials from 
multiple sites is important. Specimen should be collected form 
nasopharynx, throat, stool, blood, urine, CSF, and other body 
fluids. Swabs from throat or rectum should be placed in a 
carrying medium. Fluid specimens should be collected sterile 
vials. In general, specimen should be refrigerated immediately 
after collection and during transportation to the laboratory. If an 
extended period will elapse before examination in the laboratory, 
shipping and storing it frozen are advisable. 
During 2009 outbreaks in Korea, examinations for the 
viruses were carried out at the Division of Enteric and Hepatitis 
Viruses, Korea Centers of Diseases Control and Prevention. 
EV71 was isolated from specimens by real time-PCR. 
Viral RNA was extracted using ZR Viral RNA Kit (Zymo 
Research, Orange, CA, USA) according to the manufacturer’s 
instructions. The whole genomic RNA was reverse transcribed 
for cDNA synthesis. Amplicons of the VP1 genes were 
generated by using primers as follows: forward primer, SO224 
(5’-GCIATGYTIGGIACICAYRT-3’), and reverse primer, SO222 
(5’-CICCIGGIGGIAYRWACAT-3’) (1st-PCR); forward primer, 
AN89 (5’-CCAGCACTGACAGCAGYNGARAYNGG-3’), 
and reverse primer, AN88 (5’-TACTGGACCACCTGGNGG
NAYRWACAT-3’) (2nd-PCR). These PCR products were then 
sequenced using ABI PRISM dye terminator cycle sequencing 
ready reaction kit (Perkin Elmer, Waltham, Massachusetts, USA), 
and run on an ABI 3100 sequencer (Applied Biosystems, Foster 
City, CA, USA). Nucleotide sequences were determined by the 
DNASTAR1).
The virus was detected from rectal swab, stool, throat, tracheal 
aspirates and CSF specimens with various detectable rates (Fig. 2).
Treatment
The mainstay of treatment for EV71 disease is supportive 
management. There is currently no specific antiviral agent to treat 
or vaccine to prevent EV71 diseases. 
All patients who demonstrate the neurological symptoms and 
signs should be hospitalized. If the patient has been diagnosed 
with uncomplicated brainstem encephalitis, close monitoring 
of the myoclonic jerks and vital signs is mandatory. Since the 
target central neurologic system is the brainstem, rather than the 
cerebrum, increased intracranial pressure is rarely encountered and 
the administration of osmotic diuretics is usually unnecessary
36). 
Treating severe EV71 brainstem encephalitis patients with 
intravenous immunoglobulin is associated with significantly 
decreased mortality by attenuated sympathetic activity and 
cytokine (IL-6 and IL-8) production. Furthermore, patients 
presenting with acute flaccid paralysis combined with pleocytosis 
in the CSF should also receive IVIG infusion. A specific 
recommendation dose is unknown. Experts recommend that 
IVIG 1 g/kg should be initiated for the first day, and if ANS 
dsyregulation does not improve, a second dose should be 
administered the following day
37). The antiviral drug pleconaril 
offers promise for the treatment of enteroviral infection. It prevents 
the virus from attachment to cellular receptors and the uncoating 
and subsequent release of viral RNA into the host cell. Pleconaril is 
not available in Korea.
Infection control and prevention
As it has been reported that some serious cases causing death 
or severe neurologic complications were associated with the EV71 
infection in 2009, EV71 infection has become an important issue  Fig. 2. Origins and numbers of samples of EV71 isolation during 2009 
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in public health in Korea. 
Public health measures, in particular, personal and environ-
mental hygiene must target daycare centers, kindergartens, 
and schools where highly susceptible children congregate. In 
Singapore, to stem the spread of infection, preschools where 
transmission persisted for more than 2 incubation periods have 
been recommended to close, and trigger criteria for voluntary 
closure were instituted in April 2008. During closure, operators are 
to clean the centers thoroughly before they are allowed to reopen. 
In addition, parents are advised to ensure that their children adopt 
high-standard personal hygiene and to keep infected children at 
home until full recovery
13).
In June 2009, Korea added HFMD and enterovirus infection 
to its list of nationally notifiable infectious diseases, for which all 
diagnosed cases must be reported within 7 days. This is expected to 
allow a more accurate and extensive survey of enterovirus infections 
nationwide and to lead to continuous collection of data about the 
incidence of EV71 infection and circulating viruses in Korea.
Prospects
Although HFMD is usually a benign disease, severe neurologic 
and cardiopulmonary complications can be developed in 
cases caused by EV71. In the Korean epidemic in 2009, these 
complications including death were reported. Because the 
outbreaks occur in a cyclical pattern, we need to establish a 
surveillance system to predict upcoming outbreaks and to develop 
adequate public health measures to control the outbreaks. 
There are many aspects to be clarified for EV71 infections 
and controls such as understanding molecular genetics of EV71 
virulence, identification of the receptor(s) for EV71, development of 
antiviral agents to ameliorate neurological disease and development 
of vaccine to prevent infection.
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